Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

acyclovir

acyclovir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Zovirax CAPSULE, ORAL 200 mg      
Zovirax SOLUTION, INTRAVENOUS 50 mg/mL      
Zovirax SUSPENSION, ORAL 200 mg/5 mL      
Sitavig TABLET, BUCCAL 50 mg    
Zovirax TABLET, ORAL 400 mg, 800 mg      
VIEW MORE Nucleosides and Nucleotides
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

acyclovir (Sitavig)

  • 50 mg ONCE

valACYclovir (Valtrex)

  • 2 g BID x 2 doses

Sitavig is classified as non-formulary, not stocked.

Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information.  CrCl calculation policy available here.

Acyclovir Weight-Based Dosing Guideline (LINKED)

 

Category A Vesicant: See Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) - ADULTS and Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) PEDIATRIC

Powerplans: HOSP Vesicant Extravasation Management Orders and PEDS Vesicant Extravasation Management Orders

 

Drug Shortage Management Strategy: NOT IN EFFECT

IV Acyclovir Shortage Management Dec 2025

 

Reviewed: August 26, 2014 (Sitavig), October 22, 2019, November 2019 (Shortage Management Strategy)

Last updated: May. 13, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved